Acute Myeloid Leukemia(AML) is a rapidly progressing cancer affecting blood and bone marrow, marked by the swift proliferation of abnormal myeloid cells. Effective treatment requires precise classification of AML subtypes. Conventional classification methods rely on manual microscopic analysis, which is time-consuming and variable, while traditional machine learning approaches often struggle with feature extraction and generalization. This underscores the need for automated detection …